A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of NST-4016 in Patients With Nonalcoholic Steatohepatitis (NASH)

Closed for enrollment

(956) 362-2378

Please contact us for more information or to learn if you are eligible to participate.

The primary objective is to evaluate the efficacy of different doses of NST-4016 on the resolution of NASH without worsening of fibrosis.

5323 S. McColl Rd., Edinburg, TX 78539

(956) 362-2390